2024 BNA Scholars announced
15th March 2024
Third-cycle studies are equivalent to four year full-time and lead to a Degree of Doctor. Those appointed to doctoral studentships shall primarily devote themselves to their studies. Those appointed to doctoral studentships may, however, work to a limited extent with educational tasks, research and administration. Before a PhD degree has been awarded, duties of this kind may not comprise more than 20 per cent of a full-time post.
The PhD education in Medical Science comprise carrying out a scientific project and completing at least 30 credits of courses at third-cycle level. The doctoral student must also write a scientific compilation thesis or monograph corresponding to at least 120 credits. For more information about third-cycle studies at Sahlgrenska Academy, click here
Project: Current efforts of dealing with Alzheimer’s disease (AD) pose an immense societal challenge, particularly as there are still no curative treatments as the pathogenic mechanisms of AD are not understood. The major hallmark of AD is the progressive accumulation of Aβ and hyperphosphorylated-tau protein, into intra- and extracellular deposits. Although Aβ has been suggested to be a critical inducer of seeding neurotoxic plaque and tangle pathology, the exact mechanisms underlying Aβ plaque pathology remain elusive. It is therefore critical to elucidate how Aβ is aggregating at the single cell level.
The major methodology in this research is based on molecular imaging using both super resolution microscopy and imaging mass spectrometry. The aim is to study chemical changes in brain tissue both in genetic mouse models of AD as well as in Alzheimer patients. The goal is to understand where, when and how Aβ peptides aggregate over time and build different plaque structures and cause neurotoxic effects downstream.
To be eligible for third-cycle studies, the applicant must meet both the general and specific entry requirements.
A person meets the general entry requirements for third-cycle studies if he or she:
1. has been awarded a second-cycle qualification
2. has satisfied the requirements for courses comprising at least 240 credits of which at least 60 credits were awarded in the second-cycle, or
3. has acquired substantially equivalent knowledge in some other way in Sweden or abroad
A person meets the specific entry requirements for third-cycle studies in Medical Science if he or she: has successfully completed the English B/6 course or is considered to have acquired equivalent knowledge through previous studies
In selecting between applicants who meet the general and specific entry requirements, their ability to benefit from third-cycle studies shall be taken into account. The assessment shall attach particular importance to documented qualifications for:
- specific knowledge and skills within the subject area and related research fields
- experience of scientific theory and relevant research methodology
- scientific analysis and presentation verified through thesis, degree project, scientific journals or the like.
After admission to third-cycle studies you will be appointed to doctoral studentship. Regulations for employment of doctoral students are given in SFS 1993:100. The initial appointment may apply for no longer than one year. An appointment may be renewed for no more than two years at a time. A person may be appointed to a doctoral studentship for a total of eight years. The total employment period may, however, not exceed the time corresponding to full-time third-cycle study for four years.
Location: Sahlgrenska Academy, Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry. Extent: 100%. First day of employment: as agreed.
Salaries for doctoral students are regulated in a local agreement at the University.
For more information, click here.
For more information about the project please contact:
Principal supervisor Jörg Hanrieder, Associate Professor, e-mail: jh@gu.se
Assistant supervisor Kaj Blennow, Professor, e-mail: kaj.blennow@neuro.gu.se
Assistant supervisor Henrik Zetterberg, Professor, e-mail: henrik.zetterberg@clinchem.gu.se